Figure 1From: Severe bleeding tendency caused by a rare complication of excessive fibrinolysis with disseminated intravascular coagulation in a 51-year-old Japanese man with prostate cancer: a case report Clinical course of the patient. α2-AP: α2-antiplasmin; FDP: fibrin and/or fibrinogen degradation product; LMWH: low-molecular-weight heparin; PAP: plasmin-α2-antiplasmin complex; TAT: thrombin-antithrombin complex; TX: tranexamic acid. Open square: TAT; open circle: FDP; closed triangle: D-dimer; open diamonds: PAP; closed circle: fibrinogen; closed square: α2-AP.Back to article page